INDICATIONS
Cabozanix is a kinase inhibitor indicated for the treatment of patients with progressive, metastatic medullary thyroid cancer (MTC).
HEAD OFFICE
Beacon Pharmaceuticals Limited
9/B/2,Toyenbee Circular Road,
Motijheel,Dhaka-1223, Bangladesh.
Phone: +880-2-57165371-79
E-mail: [email protected]
Web: beaconpharma.com.bd
GLOBAL MARKETING PARTNER
Beacon Medicare Limited
9/B/2,Toyenbee Circular Road,
Motijheel,Dhaka-1223, Bangladesh.
Phone: +880-2-57165371-79
E-mail: [email protected]
Web: beaconmedicare.com.bd
